[
    [
        {
            "time": "",
            "original_text": "上半年192家公司定增：募资3000亿 朱少醒连续四个季度加仓埃斯顿 景林定增大宝股份浮亏34%",
            "features": {
                "keywords": [
                    "定增",
                    "募资",
                    "朱少醒",
                    "加仓",
                    "埃斯顿",
                    "景林",
                    "大宝股份",
                    "浮亏"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制造业",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上半年192家公司定增：募资3000亿 朱少醒连续四个季度加仓埃斯顿 景林定增大宝股份浮亏34%",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "血制品行业深度报告：国家生物安全战略物资，血制品行业迎来大机遇！【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "血制品",
                    "行业",
                    "国家生物安全",
                    "战略物资",
                    "大机遇",
                    "东吴医药",
                    "朱国广团队"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "血制品行业深度报告：国家生物安全战略物资，血制品行业迎来大机遇！【东吴医药朱国广团队】",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]